These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10083043)

  • 1. Quantitative analysis of PDGFA, PDGFB, PDGF receptor beta and TGF-beta 1 mRNA in cardiac transplant biopsies.
    Egan MK; Langham RG; Richardson M; Bergin P; Kaye D; Bailey M; Dowling J; Thomson NM; Stein-Oakley AN
    Transplant Proc; 1999; 31(1-2):131-2. PubMed ID: 10083043
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine A downregulates intragraft platelet-derived growth factor-alpha mRNA expression after clinical heart transplantation.
    de Groot-Kruseman HA; Baan CC; Mol WM; Niesters HG; Maat AP; Balk AH; Weimar W
    Transplant Proc; 2001 May; 33(3):2241-3. PubMed ID: 11377515
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential intragraft cytokine messenger RNA profiles during rejection and repair of clinical heart transplants. A longitudinal study.
    de Groot-Kruseman HA; Mol WM; Niesters HG; Maat AP; van Gelder T; Balk AH; Weimar W; Baan CC
    Transpl Int; 2003 Jan; 16(1):9-14. PubMed ID: 12545335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of cardiovascular risk factors in heart transplant recipients after conversion from cyclosporine to tacrolimus: a role of the TGF-beta system.
    van Riemsdijk IC; Baan CC; Balk AH; Vantrimpont PM; Maat LP; Weimar W
    Transplant Proc; 2002 Aug; 34(5):1864-5. PubMed ID: 12176606
    [No Abstract]   [Full Text] [Related]  

  • 5. Upregulated transforming growth factor-beta 1 mRNA expression in endomyocardial biopsies during the development of graft vascular disease after clinical heart transplantation.
    de Groot-Kruseman HA; Baan CC; Mol WM; Niesters HG; Maat AP; Balk AH; Weimar W
    Transplant Proc; 1999 Nov; 31(7):2724-5. PubMed ID: 10578265
    [No Abstract]   [Full Text] [Related]  

  • 6. Intragraft cytokine expression in heart transplants with mild or no histological rejection.
    Alvarez CM; Fernández D; Builes M; Zabaleta J; Restrepo LM; Villegas A; García LF
    Clin Transplant; 2001 Aug; 15(4):228-35. PubMed ID: 11683815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
    Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S
    Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of transforming growth factor-beta and profibrogenic molecules in a rat cardiac allograft model treated with cyclosporine.
    Khanna AK; Hosenpud JS; Plummer MS; Hosenpud JD
    Transplantation; 2002 May; 73(10):1543-9. PubMed ID: 12042638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Oct; 38(8):2719-21. PubMed ID: 17098049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of TGF-beta and PDGF-AA antigens and corresponding mRNAs in cytomegalovirus-infected rat kidney allografts.
    Inkinen K; Holma K; Soots A; Krogerus L; Loginov R; Bruggeman C; Ahonen J; Lautenschlager I
    Transplant Proc; 2003 Mar; 35(2):804-5. PubMed ID: 12644146
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased transcript levels of TNF-alpha, TGF-beta, and granzyme B in endomyocardial biopsies correlate with allograft rejection.
    Ramsperger-Gleixner M; Spriewald BM; Tandler R; Kondruweit M; Amann K; Weyand M; Ensminger SM
    Exp Clin Transplant; 2011 Dec; 9(6):387-92. PubMed ID: 22142046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of rejection on late graft function after heart transplantation.
    Livi U; Milano A; Caforio AL; Grassi G; Feltrin G; Boffa GM; D'Agnolo A; Angelini A; Thiene G; Casarotto D
    Transplant Proc; 1994 Oct; 26(5):2727-8. PubMed ID: 7940855
    [No Abstract]   [Full Text] [Related]  

  • 13. Involvement of interleukin-2 and growth factors in chronic kidney allograft rejection in rats.
    Hamar P; Szabó A; Müller V; Heemann U
    Transplant Proc; 2001 May; 33(3):2160-2. PubMed ID: 11377486
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A.
    Behr TM; Richter K; Fischer P; Spes CH; Meiser B; Reichart B; Pongratz D; Feucht H; Theisen K; Angermann CE
    Transplant Proc; 1998 Aug; 30(5):1920-1. PubMed ID: 9723333
    [No Abstract]   [Full Text] [Related]  

  • 15. Microsatellites and intragenic polymorphisms of transforming growth factor beta and platelet-derived growth factor and their receptor genes in Native Americans with systemic sclerosis (scleroderma): a preliminary analysis showing no genetic association.
    Zhou X; Tan FK; Stivers DN; Arnett FC
    Arthritis Rheum; 2000 May; 43(5):1068-73. PubMed ID: 10817561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and structural consequences of early renal allograft injury.
    Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
    Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation.
    Nykänen AI; Krebs R; Tikkanen JM; Raisky O; Sihvola R; Wood J; Koskinen PK; Lemström KB
    Transplantation; 2005 Jan; 79(2):182-9. PubMed ID: 15665766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive monitoring of rejection therapy based on intramyocardial electrograms after orthotopic heart transplantation.
    Grasser B; Schreier G; Iberer F; Wasler A; Petutschnigg B; Müller H; Prenner G; Hipmair G; Hutten H; Schaldach M; Tscheliessnigg KH
    Transplant Proc; 1996 Dec; 28(6):3276-7. PubMed ID: 8962272
    [No Abstract]   [Full Text] [Related]  

  • 19. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose oral prednisone in the treatment of acute cardiac allograft rejection.
    Delgado JF; Pombo M; Dalmau R; Gómez-Sánchez MA; Escribano P; Lázaro M; Velázquez MT; Sánchez V; Sáenz de la Calzada C; Rufilanchas JJ
    Transplant Proc; 2002 Feb; 34(1):117. PubMed ID: 11959215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.